[Pneumatosis cystoides intestinalis following steroid treatment in a nephrotic syndrome patient: report of a case]. | Canada Hyperbarics Skip to main content
Clinical Study Nihon Jinzo Gakkai shi 1993

[Pneumatosis cystoides intestinalis following steroid treatment in a nephrotic syndrome patient: report of a case].

Iitsuka T, Kobayashi M, Izumi Y, Koyama A — Nihon Jinzo Gakkai shi, 1993

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported on a 28-year-old female patient with nephrotic syndrome who developed pneumatosis cystoides intestinalis (PCI) after long-term steroid treatment.

What They Found

A 28-year-old female patient with nephrotic syndrome developed pneumatosis cystoides intestinalis (PCI) seven weeks after an increased steroid dosage of 60mg/day. Imaging confirmed gas-filled cysts in the bowel wall, and her PCI symptoms improved with high flow oxygen and hyperbaric oxygen therapy.

What This Means for Canadian Patients

Canadian patients receiving long-term steroid treatment for conditions like nephrotic syndrome should be aware of potential rare side effects such as pneumatosis cystoides intestinalis (PCI). Prompt reporting of new abdominal pain or fullness to their healthcare provider can facilitate early diagnosis and appropriate management, including oxygen therapy if PCI is confirmed.

Canadian Relevance

This study has no direct Canadian connection as it is a case report from Japan.

Study Limitations

As a single case report, this study's findings cannot be generalized to a broader patient population.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Wound Care
Source Pubmed
PubMed ID 8501860
Year Published 1993
Journal Nihon Jinzo Gakkai shi
MeSH Terms Adult; Female; Humans; Nephrotic Syndrome; Pneumatosis Cystoides Intestinalis; Prednisolone

Cite This Study

Share

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.